Wasilewska, E.; Sobierajska-Rek, A.; Śledzińska, K.; Małgorzewicz, S.; Jassem, E.; Wierzba, J.
Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey. Int. J. Environ. Res. Public Health 2022, 19, 406.
https://doi.org/10.3390/ijerph19010406
AMA Style
Wasilewska E, Sobierajska-Rek A, Śledzińska K, Małgorzewicz S, Jassem E, Wierzba J.
Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey. International Journal of Environmental Research and Public Health. 2022; 19(1):406.
https://doi.org/10.3390/ijerph19010406
Chicago/Turabian Style
Wasilewska, Eliza, Agnieszka Sobierajska-Rek, Karolina Śledzińska, Sylwia Małgorzewicz, Ewa Jassem, and Jolanta Wierzba.
2022. "Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey" International Journal of Environmental Research and Public Health 19, no. 1: 406.
https://doi.org/10.3390/ijerph19010406
APA Style
Wasilewska, E., Sobierajska-Rek, A., Śledzińska, K., Małgorzewicz, S., Jassem, E., & Wierzba, J.
(2022). Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey. International Journal of Environmental Research and Public Health, 19(1), 406.
https://doi.org/10.3390/ijerph19010406
